Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Kamada Ltd as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −5 vs. Q4 2022
- Shares held
- 6.05M
- +329.9K (+5.8%) vs. Q4 2022
- Total value
- $28.1M
- +$4.91M (+21.1%) vs. Q4 2022
- New holders
- 1
- 7 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KMDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 51 | $36.7M |
| Q1 2026 | 43 | $38.1M |
| Q4 2025 | 46 | $33.7M |
| Q3 2025 | 46 | $37.2M |
| Q2 2025 | 39 | $40.1M |
| Q1 2025 | 35 | $34.4M |
| Q4 2024 | 23 | $37.2M |
| Q3 2024 | 30 | $34.8M |
| Q2 2024 | 30 | $31.7M |
| Q1 2024 | 28 | $31.9M |
| Q4 2023 | 29 | $36.9M |
| Q3 2023 | 25 | $30.8M |
| Q2 2023 | 23 | $31.0M |
| Q1 2023 | 23 | $28.1M |
| Q4 2022 | 28 | $23.2M |
| Q3 2022 | 32 | $31.4M |
| Q2 2022 | 35 | $32.8M |
| Q1 2022 | 37 | $37.1M |
| Q4 2021 | 46 | $43.6M |
| Q3 2021 | 47 | $40.7M |
| Q2 2021 | 53 | $45.4M |
| Q1 2021 | 41 | $44.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Kamada Ltd; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Phoenix Holdings Ltd. | 2,105,523 | $9.78M | 0.22% | 00.0% | Unchanged |
| Vanguard Group Inc | 997,319 | $4.63M | 0.00% | +3,471+0.3% | Added |
| Renaissance Technologies LLC | 849,205 | $3.94M | 0.01% | −6,340−0.7% | Reduced |
| Acadian Asset Management LLC | 645,717 | $3.01M | 0.01% | −32,452−4.8% | Reduced |
| Wells Fargo & Company | 638,050 | $2.99M | 0.00% | +124,174+24.2% | Added |
| Altshuler Shaham Ltd | 353,046 | $1.64M | 0.04% | +353,046 | New |
| Millennium Management LLC | 124,401 | $576.0K | 0.00% | +46,007+58.7% | Added |
| Meitav Dash Investments Ltd | 65,551 | $303.0K | 0.01% | −18,306−21.8% | Reduced |
| UBS Group AG | 47,783 | $222.0K | 0.00% | +47,257+8,984.2% | Added |
| Norges Bank | 33,595 | $157.1K | 0.00% | 00.0% | Unchanged |
| Metis Global Partners, LLC | 33,001 | $154.5K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 30,619 | $141.8K | 0.00% | +5,274+20.8% | Added |
| Geode Capital Management, LLC | 25,878 | $119.8K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 25,398 | $117.6K | 0.00% | −23,381−47.9% | Reduced |
| Calton & Associates, Inc. | 22,797 | $105.9K | 0.05% | −1,458−6.0% | Reduced |
| Goldman Sachs Group Inc | 18,069 | $83.9K | 0.00% | −12,506−40.9% | Reduced |
| Mariner, LLC | 14,325 | $67.0K | 0.00% | −750−5.0% | Reduced |
| Morgan Stanley | 9,996 | $46.4K | 0.00% | −862−7.9% | Reduced |
| Royal Bank of Canada | 3,302 | $15.0K | 0.00% | +1,903+136.0% | Added |
| Tower Research Capital LLC (TRC) | 2,415 | $11.0K | 0.00% | +526+27.8% | Added |
| Belpointe Asset Management LLC | 2,000 | $9.29K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $465 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 80 | $370 | 0.00% | −750−90.4% | Reduced |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −126,494−100.0% | Sold out |
| Y.D. More Investments Ltd | 0 | $0 | 0.00% | −17,891−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,139−100.0% | Sold out |
| Romano Brothers and Company | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |